News Category
Coherence Neuro's $45 million Series A, led by Peter Thiel's Founders Fund and the OpenAI Startup Fund, will fund the first chronic human trial of its...
A Yale study reveals that recurrent brain cancers develop mutations that differ by subtype, suggesting a shift from phenotype-based to DNA-guided trea...
ECGI Holdings has hired IBN to expand investor awareness of its health care strategy, which includes building an integrated care ecosystem and develop...
VERAXA Biotech is implementing New Approach Methodologies across its preclinical research programs, aiming to improve the clinical relevance of its an...
VERAXA Biotech is advancing its BiTAC platform to improve the selectivity of antibody-based cancer therapies, potentially reducing toxicity while main...
Bangladesh's major measles outbreak, with over 200,000 suspected cases, highlights the global risk of falling vaccination rates and serves as a cautio...
VERAXA Biotech is expanding its use of FDA-aligned New Approach Methodologies to generate more clinically relevant preclinical data while reducing ani...
Dr. Mona Mofid's ninth San Diego Top Doctor award, paired with a 2026 Top Specialist Award and perfect patient ratings, underscores a two-decade recor...
Pentixapharm's Phase 3 PANDA study for non-invasive subtyping of primary aldosteronism is reinforced by independent international data presented at EA...
A small German study's eight-year follow-up shows two-thirds of patients with aggressive brain tumors were still alive and 42% had no recurrence, unde...
TransCode Therapeutics will present updated Phase 1a clinical data for its lead candidate TTX-MC138 at the ESMO Congress 2026, a key event that could ...
Creative BioTherapeutics' nomination for the 2026 Prix Galien USA Best Startup award highlights its preclinical work on CBT300, an investigational bio...
A new clinical trial reveals that an experimental vaccine extends survival in glioblastoma patients, signaling potential progress after decades of sta...
Artificial intelligence and new imaging tools are poised to reshape breast cancer screening, enabling earlier detection and more personalized recommen...
VERAXA Biotech presented first in vivo proof-of-concept data for its BiTAC-ADC platform, demonstrating significant tumor regression in a breast cancer...
A UK study reveals that clearing immune fog could stop lung cancer before diagnosis, potentially revolutionizing early intervention and spurring advan...
VERAXA Biotech presented first in vivo proof-of-concept data for its BiTAC-ADC technology at the World ADC Congress, demonstrating significant tumor r...
A modeling analysis presented at the American Heart Association's Hypertension Scientific Sessions 2026 shows that expanding high blood pressure treat...
Rising flu infections ahead of the typical season underscore the urgent need for expanded community-level diagnostic capacity as vaccine timing recomm...
Consultwebs is providing a $50 stipend and half-day paid time off to employees who get a mammogram in 2026, aiming to boost early detection and inspir...
Avident Health and Unite for HER have been awarded a quality improvement grant from Pfizer and NCCN to deploy a digital navigation platform that bridg...
The American College of Radiology now recommends all women undergo a breast cancer risk assessment by age 25, a shift that could lead to earlier detec...
VERAXA Biotech's adoption of FDA-aligned New Approach Methodologies could accelerate clinical advancement and cut animal testing by up to 95% for its ...
Lantern Pharma's Taiwan regulatory and IRB approvals for Part 2 of its Phase 2 HARMONIC trial of LP-300 could accelerate development of a targeted the...
VERAXA Biotech's adoption of FDA-aligned New Approach Methodologies could dramatically reduce animal testing, cut costs, and speed up clinical develop...
Telomir Pharmaceuticals secures $5.6 million in PIPE financing to fund clinical development of Telomir-Zn, including a Phase 1/2 trial in advanced tri...
A new study reveals that the skull bone marrow contains lymph node-like structures that could serve as a local immune defense for the brain, opening n...
Kairos Pharma's ENV-105 combined with apalutamide significantly extended progression-free survival in metastatic castration-resistant prostate cancer ...
GeoVax will present its next-generation MVA-X technology and continuous cell-line manufacturing platform at World Vaccine Congress Europe 2026, potent...
The Hong Kong Convention and Exhibition Centre hosted 786 events in FY 2025–2026, including 25 new exhibitions and conferences, reinforcing Hong Kong'...
A new intraoperative test that identifies a brain tumor's genetic makeup in about two hours instead of eight weeks could accelerate diagnosis and impr...
A new blood-based approach to identifying cancer neoantigens and T-cell activation could eliminate the need for surgical tumor sampling in immunothera...
Mega Bee Rescues & Pest Control is turning its signature yellow bee pink and donating 5% of its October pest control and bee removal services to suppo...
A new forecast warns that over three million UK children will become short-sighted by adulthood, highlighting the critical need for early detection an...
Blue Faery will host a free liver cancer education event at University of Chicago Medicine on October 24, 2026, aiming to improve outcomes through bet...
A board-certified vascular surgeon in Clifton, New Jersey, is treating venous lake—a common but often misunderstood benign lip lesion—with laser thera...
Onco-Innovations is advancing its preclinical oncology candidate ONC010 toward clinical trials by achieving a 300-gram API scale-up with 99.3% purity,...
A recent report reveals that billions of pounds of cancer-causing chemicals entered the U.S. air in 2020, underscoring the urgent need for both preven...
BIOT's non-exclusive appointment to represent CelSiege's IN01 cancer immunotherapy in Japan and China signals a strategic expansion into clinical-stag...
Nashville Concierge Medicine has published a new article explaining how ADHD can disrupt sleep in adults, emphasizing the importance of professional e...
VERAXA Biotech (NASDAQ: VRXA) has moved its VXA-222 bispecific antibody-drug conjugate program beyond discovery, planning further preclinical developm...
Nutriband CEO Gareth Sheridan appears in a new documentary examining the U.S. opioid crisis, highlighting the company's AVERSA abuse-deterrent technol...
The CDC's new assessment indicating likely sustained Clade Ib mpox transmission in the U.S. underscores the need for ongoing surveillance and vaccine ...
Novogenia AG's H1 2026 report shows revenue decline but core business growth and strategic progress, signaling a pivot to personalized health.
Researchers in South Korea have identified a protein that controls brain cancer growth, potentially leading to new treatments for glioblastoma, a high...
TransCode Therapeutics' TTX-MC138 shows promising disease control and safety in Phase 1a trial, with 71.4% of efficacy-evaluable patients achieving st...
Psychiatrist Dr. Amar Surdhar's support for the HAS Foundation highlights the critical need for interdisciplinary collaboration and compassionate care...
VERAXA Biotech is advancing its oncology pipeline and seeking industrial partnerships following its Nasdaq debut, while parent Xlife Sciences reports ...
